{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:14:05Z","timestamp":1790828045629,"version":"4.1.0"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7222059"],"award-info":[{"award-number":["7222059"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002130"],"award-info":[{"award-number":["82002130"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2019-I2M-5-026"],"award-info":[{"award-number":["2019-I2M-5-026"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.meegid.2023.105443","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T01:14:57Z","timestamp":1684286097000},"page":"105443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["T cell-mediated immunity during Epstein\u2013Barr virus infections in children"],"prefix":"10.1016","volume":"112","author":[{"given":"Mengjia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengde","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2023.105443_bb0005","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.4049\/jimmunol.1301629","article-title":"CD8+ T cell responses to lytic EBV infection: late antigen specificities as subdominant components of the total response","volume":"191","author":"Abbott","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0010","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00382-17","article-title":"Asymptomatic primary infection with Epstein-Barr virus: observations on young adult cases","volume":"91","author":"Abbott","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0015","first-page":"448","article-title":"Recurrent and non-recurrent pigmented villonodular synovitis 1","volume":"22","author":"Adem","year":"2002","journal-title":"Ann. Pathol."},{"key":"10.1016\/j.meegid.2023.105443_bb0020","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00284-20","article-title":"The Epstein-Barr virus major tegument protein BNRF1 is a common target of cytotoxic CD4(+) T cells","volume":"94","author":"Adhikary","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0025","first-page":"9","article-title":"Targeted delivery of BZLF1 to DEC205 drives EBV-protective immunity in a spontaneous model of EBV-driven lymphoproliferative disease","author":"Ahmed","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.meegid.2023.105443_bb0030","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fped.2018.00289","article-title":"Epstein-Barr virus-positive T\/NK-cell lymphoproliferative diseases in Chinese Mainland","volume":"6","author":"Ai","year":"2018","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.meegid.2023.105443_bb0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1182\/asheducation-2015.1.177","article-title":"Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis","volume":"2015","author":"Allen","year":"2015","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"10.1016\/j.meegid.2023.105443_bb0040","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1084\/jem.20022058","article-title":"Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection","volume":"198","author":"Amyes","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.meegid.2023.105443_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004333","article-title":"Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice","volume":"10","author":"Antsiferova","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.meegid.2023.105443_bb0050","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/JVI.01369-08","article-title":"mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1","volume":"83","author":"Apcher","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0055","doi-asserted-by":"crossref","first-page":"5954","DOI":"10.4049\/jimmunol.168.11.5954","article-title":"Characterization of CD4(+) CTLs ex vivo","volume":"168","author":"Appay","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9010180","article-title":"Chronic active Epstein-Barr virus infection: the elucidation of the pathophysiology and the development of therapeutic methods","volume":"9","author":"Arai","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.meegid.2023.105443_bb0065","first-page":"879","article-title":"Diagnosis and treatment of infectious mononucleosis","volume":"49","author":"Bailey","year":"1994","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.meegid.2023.105443_bb0070","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jis646","article-title":"Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students","volume":"207","author":"Balfour","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2023.105443_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2015.1","article-title":"Infectious mononucleosis","volume":"4","author":"Balfour","year":"2015","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0080","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fimmu.2019.00146","article-title":"Revisiting the tissue microenvironment of infectious mononucleosis: identification of EBV infection in T cells and deep characterization of immune profiles","volume":"10","author":"Barros","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0085","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1182\/blood-2018-03-785931","article-title":"How I treat T-cell chronic active Epstein-Barr virus disease","volume":"131","author":"Bollard","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.meegid.2023.105443_bb0090","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nm0602-594","article-title":"Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus","volume":"8","author":"Borza","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.meegid.2023.105443_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005549","article-title":"Early T cell recognition of B cells following Epstein-Barr virus infection: identifying potential targets for prophylactic vaccination","volume":"12","author":"Brooks","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.meegid.2023.105443_bb0100","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.immuni.2019.03.010","article-title":"Immunization with components of the viral fusion apparatus elicits antibodies that neutralize Epstein-Barr virus in B cells and epithelial cells","volume":"50","author":"Bu","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.meegid.2023.105443_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.592569","article-title":"Helpless priming sends CD8(+) T cells on the road to exhaustion","volume":"11","author":"Busselaar","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0110","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/imm.12106","article-title":"Detection of Epstein-Barr virus-specific memory CD4+ T cells using a peptide-based cultured enzyme-linked immunospot assay","volume":"139","author":"Calarota","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.meegid.2023.105443_bb0115","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.187.9.1395","article-title":"Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo","volume":"187","author":"Callan","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.meegid.2023.105443_bb0120","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.4049\/jimmunol.168.8.4184","article-title":"Phenotypic and functional heterogeneity of EBV epitope-specific CD8+ T cells","volume":"168","author":"Catalina","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0125","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1007\/s11033-010-0571-7","article-title":"Molecular analysis and expression of a floral organ-relative F-box gene isolated from \u2018Zigui shatian\u2019 pummelo (Citrus grandis Osbeck)","volume":"38","author":"Chai","year":"2011","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.meegid.2023.105443_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007748","article-title":"CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo","volume":"15","author":"Chatterjee","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.meegid.2023.105443_bb0135","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1182\/blood.V98.1.156","article-title":"CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection","volume":"98","author":"Chen","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.meegid.2023.105443_bb0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/cmi.2009.36","article-title":"EBV LMP2A-specific T cell immune responses elicited by dendritic cells loaded with LMP2A protein","volume":"6","author":"Chen","year":"2009","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0145","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41564-017-0081-7","article-title":"Ephrin receptor A2 is a functional entry receptor for Epstein-Barr virus","volume":"3","author":"Chen","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.meegid.2023.105443_bb0150","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00081-21","article-title":"T cell epitope screening of Epstein-Barr virus fusion protein gB","author":"Chen","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0155","doi-asserted-by":"crossref","first-page":"13214","DOI":"10.1128\/JVI.05580-11","article-title":"Fusion of Epstein-Barr virus with epithelial cells can be triggered by alphavbeta5 in addition to alphavbeta6 and alphavbeta8, and integrin binding triggers a conformational change in glycoproteins gHgL","volume":"85","author":"Chesnokova","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0160","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00262-018-2118-z","article-title":"Epstein-Barr virus strain heterogeneity impairs human T-cell immunity","volume":"67","author":"Cirac","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.meegid.2023.105443_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.796379","article-title":"Immunoinformatic analysis reveals antigenic heterogeneity of Epstein-Barr virus is immune-driven","volume":"12","author":"Cirac","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0170","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.meegid.2023.105443_bb0175","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/978-981-10-7230-7_22","article-title":"Vaccine development for Epstein-Barr virus","volume":"1045","author":"Cohen","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.meegid.2023.105443_bb0180","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1182\/blood.2020005611","article-title":"Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells","volume":"137","author":"Collins","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.meegid.2023.105443_bb0185","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41579-020-00448-w","article-title":"The structural basis of herpesvirus entry","volume":"19","author":"Connolly","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.meegid.2023.105443_bb0190","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00375-17","article-title":"Natural variation of Epstein-Barr virus genes, proteins, and primary MicroRNA","volume":"91","author":"Correia","year":"2017","journal-title":"J. Virol."},{"issue":"Suppl. 1","key":"10.1016\/j.meegid.2023.105443_bb0195","first-page":"S156","article-title":"Epstein-Barr virus: biology and disease","volume":"3","author":"Cruchley","year":"1997","journal-title":"Oral Dis."},{"key":"10.1016\/j.meegid.2023.105443_bb0200","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1016\/j.vaccine.2016.06.021","article-title":"Rabbits immunized with Epstein-Barr virus gH\/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350","volume":"34","author":"Cui","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2023.105443_bb0205","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0010-9452(85)80005-8","article-title":"Analysis of prosody in the spontaneous speech of patients with CV-recurring utterances","volume":"21","author":"de Bleser","year":"1985","journal-title":"Cortex"},{"key":"10.1016\/j.meegid.2023.105443_bb0210","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1182\/blood.2020009482","article-title":"CD27 is required for protective lytic EBV antigen-specific CD8+ T-cell expansion","volume":"137","author":"Deng","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.meegid.2023.105443_bb0215","doi-asserted-by":"crossref","first-page":"15088","DOI":"10.1038\/nrdp.2015.88","article-title":"Post-transplant lymphoproliferative disorders","volume":"2","author":"Dharnidharka","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.meegid.2023.105443_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010137","article-title":"Cytotoxic CD4+ T-cells specific for EBV capsid antigen BORF1 are maintained in long-term latently infected healthy donors","volume":"17","author":"Dowell","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.meegid.2023.105443_bb0225","first-page":"211","article-title":"Infectious mononucleosis","volume":"390","author":"Dunmire","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0230","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcv.2018.03.001","article-title":"Primary Epstein-Barr virus infection","volume":"102","author":"Dunmire","year":"2018","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0235","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1182\/blood-2002-01-0160","article-title":"Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential","volume":"100","author":"Dunne","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.meegid.2023.105443_bb0240","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1128\/JVI.01409-07","article-title":"Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis","volume":"82","author":"Elliott","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0245","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/bjh.17638","article-title":"Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes","volume":"196","author":"El-Mallawany","year":"2022","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.meegid.2023.105443_bb0250","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.meegid.2023.105443_bb0255","first-page":"45","article-title":"Epstein-Barr Virus Strain Variation","volume":"390","author":"Farrell","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0260","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-pathmechdis-012418-013023","article-title":"Epstein-Barr virus and cancer","volume":"14","author":"Farrell","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.meegid.2023.105443_bb0265","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/infdis\/jiaa601","article-title":"The nature and clinical significance of atypical mononuclear cells in infectious mononucleosis caused by the Epstein-Barr virus in children","volume":"223","author":"Fedyanina","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2023.105443_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007110","article-title":"Proteome-wide analysis of CD8+ T cell responses to EBV reveals differences between primary and persistent infection","volume":"14","author":"Forrest","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.meegid.2023.105443_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113202","article-title":"Chronic active Epstein-Barr virus infection: is it immunodeficiency, malignancy, or both?","volume":"12","author":"Fujiwara","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.meegid.2023.105443_bb0280","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0285","first-page":"171","article-title":"First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen","volume":"84","author":"Gu","year":"1995","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.meegid.2023.105443_bb0290","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11596-021-2375-5","article-title":"Inherited genetic susceptibility to nonimmunosuppressed Epstein-Barr virus-associated T\/NK-cell lymphoproliferative diseases in Chinese patients","volume":"41","author":"Guan","year":"2021","journal-title":"Curr. Med. Sci."},{"key":"10.1016\/j.meegid.2023.105443_bb0295","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1182\/blood-2008-03-148072","article-title":"Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses","volume":"112","author":"Gurer","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.meegid.2023.105443_bb0300","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.vaccine.2016.04.012","article-title":"Identification of GLA\/SE as an effective adjuvant for the induction of robust humoral and cell-mediated immune responses to EBV-gp350 in mice and rabbits","volume":"34","author":"Heeke","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2023.105443_bb0305","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01926-15","article-title":"Consideration of Epstein-Barr virus-encoded noncoding RNAs EBER1 and EBER2 as a functional backup of viral oncoprotein latent membrane protein 1","volume":"7","author":"Herbert","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.meegid.2023.105443_bb0310","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.4049\/jimmunol.167.4.2019","article-title":"EBV-specific CD8+ T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function","volume":"167","author":"Hislop","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0315","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1172\/JCI24810","article-title":"Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balance","volume":"115","author":"Hislop","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.meegid.2023.105443_bb0320","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","article-title":"Cellular responses to viral infection in humans: lessons from Epstein-Barr virus","volume":"25","author":"Hislop","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0325","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.4049\/jimmunol.163.10.5735","article-title":"Antigen-driven expansion and contraction of CD8+-activated T cells in primary EBV infection","volume":"163","author":"Hoshino","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0330","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jcv.2010.11.017","article-title":"Kinetics of Epstein-Barr virus load and virus-specific CD8+ T cells in acute infectious mononucleosis","volume":"50","author":"Hoshino","year":"2011","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0335","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/ped4.12294","article-title":"Clinical characteristics and effectiveness of antiviral agents in hospitalized children with infectious mononucleosis in China: a multicenter retrospective study","volume":"5","author":"Hu","year":"2021","journal-title":"Pediatr. Investig."},{"key":"10.1016\/j.meegid.2023.105443_bb0340","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.intimp.2019.05.037","article-title":"Advancing immunomodulation by in vivo antigen delivery to DEC-205 and other cell surface molecules using recombinant chimeric antibodies","volume":"73","author":"Iberg","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.meegid.2023.105443_bb0345","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1111\/apa.15973","article-title":"Virus-triggered secondary hemophagocytic lymphohistiocytosis","volume":"110","author":"Imashuku","year":"2021","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.meegid.2023.105443_bb0350","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fped.2016.00047","article-title":"Hemophagocytic lymphohistiocytosis in children: pathogenesis and treatment","volume":"4","author":"Ishii","year":"2016","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.meegid.2023.105443_bb0355","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1084\/jem.20160784","article-title":"Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection","volume":"214","author":"Izawa","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.meegid.2023.105443_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004746","article-title":"Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children","volume":"11","author":"Jayasooriya","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.meegid.2023.105443_bb0365","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00008480-200006000-00016","article-title":"Acute complications of Epstein-Barr virus infectious mononucleosis","volume":"12","author":"Jenson","year":"2000","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.meegid.2023.105443_bb0370","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","article-title":"Rational design of an Epstein-Barr virus vaccine targeting the receptor-binding site","volume":"162","author":"Kanekiyo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.meegid.2023.105443_bb0375","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1182\/blood.V98.6.1882","article-title":"Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection","volume":"98","author":"Kasahara","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.meegid.2023.105443_bb0380","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1182\/blood-2003-06-2171","article-title":"Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation","volume":"103","author":"Katano","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.meegid.2023.105443_bb0385","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3389\/fimmu.2017.01867","article-title":"Chronic active Epstein-Barr virus disease","volume":"8","author":"Kimura","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0390","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/427239","article-title":"Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection","volume":"191","author":"Kimura","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2023.105443_bb0395","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/rmv.582","article-title":"Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease","volume":"18","author":"Kimura","year":"2008","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0400","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.meegid.2023.105443_bb0405","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3389\/fimmu.2020.01593","article-title":"CD70 deficiency associated with chronic Epstein-Barr virus infection, recurrent airway infections and severe gingivitis in a 24-year-old woman","volume":"11","author":"Kruger","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0410","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3389\/fmicb.2018.00416","article-title":"Emergence of CD4+ and CD8+ polyfunctional T cell responses against immunodominant lytic and latent EBV antigens in children with primary EBV infection","volume":"9","author":"Lam","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.meegid.2023.105443_bb0415","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2003-03-0930","article-title":"Direct killing of Epstein-Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1","volume":"103","author":"Landais","year":"2004","journal-title":"Blood"},{"issue":"6011","key":"10.1016\/j.meegid.2023.105443_bib821","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/314537a0","article-title":"Antigen-specific interaction between T and B cells","volume":"314","author":"Lanzavecchia","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2023.105443_bb0420","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/imr.12791","article-title":"Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: lessons from genetic diseases","volume":"291","author":"Latour","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.meegid.2023.105443_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/v13040702","article-title":"Conquering the nuclear envelope barriers by EBV lytic replication","volume":"13","author":"Lee","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.meegid.2023.105443_bb0430","doi-asserted-by":"crossref","first-page":"8649","DOI":"10.1128\/JVI.75.18.8649-8659.2001","article-title":"Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses","volume":"75","author":"Leen","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003076","article-title":"The polyfunctionality of human memory CD8+ T cells elicited by acute and chronic virus infections is not influenced by age","volume":"8","author":"Lelic","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.meegid.2023.105443_bb0440","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1182\/blood-2012-08-450775","article-title":"Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205","volume":"121","author":"Leung","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.meegid.2023.105443_bb0445","doi-asserted-by":"crossref","first-page":"12616","DOI":"10.1073\/pnas.94.23.12616","article-title":"Inhibition of ubiquitin\/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1","volume":"94","author":"Levitskaya","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.meegid.2023.105443_bb0450","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1128\/jvi.71.6.4657-4662.1997","article-title":"Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes","volume":"71","author":"Li","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0455","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41422-020-0363-0","article-title":"CryoEM structure of the tegumented capsid of Epstein-Barr virus","volume":"30","author":"Li","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.meegid.2023.105443_bb0460","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/s41564-020-0758-1","article-title":"Structures of capsid and capsid-associated tegument complex inside the Epstein-Barr virus","volume":"5","author":"Liu","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.meegid.2023.105443_bb0465","article-title":"Epidemiological characteristics and disease burden of infectious mononucleosis in hospitalized children in China: a nationwide retrospective study","author":"Liu","year":"2022","journal-title":"Virol. Sin."},{"key":"10.1016\/j.meegid.2023.105443_bb0470","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4049\/jimmunol.1100590","article-title":"Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition","volume":"187","author":"Long","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0475","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1084\/jem.20121437","article-title":"MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response","volume":"210","author":"Long","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.meegid.2023.105443_bb0480","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1128\/JVI.02608-06","article-title":"Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells","volume":"81","author":"MacArthur","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0485","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2141.2007.06765.x","article-title":"CD4(+) T-cell responses to Epstein-Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV-associated non-Hodgkin lymphoma: Th1 in active disease but Tr1 in remission","volume":"139","author":"Marshall","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.meegid.2023.105443_bb0490","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/08830185.2010.489658","article-title":"Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer","volume":"29","author":"Martorelli","year":"2010","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0495","first-page":"237","article-title":"Epstein-Barr virus lytic cycle reactivation","volume":"391","author":"McKenzie","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0500","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.4049\/jimmunol.1900377","article-title":"Primary EBV infection induces an acute wave of activated antigen-specific cytotoxic CD4(+) T cells","volume":"203","author":"Meckiff","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0505","first-page":"61","article-title":"Epigenotypes of latent herpesvirus genomes","volume":"310","author":"Minarovits","year":"2006","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0510","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1128\/JVI.74.14.6324-6332.2000","article-title":"Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells","volume":"74","author":"Molesworth","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0515","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/sj.cdd.4401748","article-title":"Unilineage monocytopoiesis in hematopoietic progenitor culture: switching cytokine treatment at all Mo developmental stages induces differentiation into dendritic cells","volume":"13","author":"Montesoro","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.meegid.2023.105443_bb0520","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/CJI.0b013e31824d72c5","article-title":"EBV latency II-derived peptides induce a specific CD4+ cytotoxic T-cell activity and not a CD4+ regulatory T-cell response","volume":"35","author":"Morales","year":"2012","journal-title":"J. Immunother."},{"key":"10.1016\/j.meegid.2023.105443_bb0525","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061400","article-title":"Redirecting T cells against Epstein-Barr virus infection and associated oncogenesis","volume":"9","author":"Munz","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.meegid.2023.105443_bb0530","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1084\/jem.191.10.1649","article-title":"Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1","volume":"191","author":"Munz","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.meegid.2023.105443_bb0535","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.micinf.2014.04.004","article-title":"PCR array analysis of gene expression profiles in chronic active Epstein-Barr virus infection","volume":"16","author":"Murakami","year":"2014","journal-title":"Microbes Infect."},{"key":"10.1016\/j.meegid.2023.105443_bb0540","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/1348-0421.12155","article-title":"Regulation of Epstein-Barr virus reactivation from latency","volume":"58","author":"Murata","year":"2014","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0545","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2567.2011.03476.x","article-title":"Long-term carriers generate Epstein-Barr virus (EBV)-specific CD4(+) and CD8(+) polyfunctional T-cell responses which show immunodominance hierarchies of EBV proteins","volume":"134","author":"Ning","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.meegid.2023.105443_bb0550","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1128\/CMR.00044-10","article-title":"Progress and problems in understanding and managing primary Epstein-Barr virus infections","volume":"24","author":"Odumade","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.meegid.2023.105443_bb0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/317653","article-title":"Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection","volume":"183","author":"Ohga","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2023.105443_bb0560","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/jmv.20197","article-title":"Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection","volume":"74","author":"Ohga","year":"2004","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0565","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ajh.20398","article-title":"Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection","volume":"80","author":"Okano","year":"2005","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.meegid.2023.105443_bb0570","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.vaccine.2019.02.050","article-title":"Targeting M2e to DEC-205 induces an enhanced serum antibody-dependent heterosubtypic protection against influenza A virus infection","volume":"37","author":"Padilla-Quirarte","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2023.105443_bb0575","doi-asserted-by":"crossref","first-page":"19255","DOI":"10.18632\/oncotarget.13770","article-title":"Novel Epstein-Barr virus-like particles incorporating gH\/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice","volume":"8","author":"Perez","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.meegid.2023.105443_bb0580","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.4049\/jimmunol.170.5.2590","article-title":"Differential kinetics and specificity of EBV-specific CD4+ and CD8+ T cells during primary infection","volume":"170","author":"Precopio","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0585","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/B978-0-12-800098-4.00006-4","article-title":"Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation","volume":"88","author":"Price","year":"2014","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.meegid.2023.105443_bb0590","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10238-020-00621-8","article-title":"Altered ratio of circulating follicular regulatory T cells and follicular helper T cells during primary EBV infection","volume":"20","author":"Qian","year":"2020","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.meegid.2023.105443_bb0595","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/MPH.0b013e31822d4ea7","article-title":"Prevalence of coinfection in children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"34","author":"Qiang","year":"2012","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.meegid.2023.105443_bb0600","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/intimm\/12.3.281","article-title":"A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4(+) T lymphocytes","volume":"12","author":"Rajnavolgyi","year":"2000","journal-title":"Int. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0605","doi-asserted-by":"crossref","first-page":"11583","DOI":"10.1073\/pnas.2034960100","article-title":"Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition","volume":"100","author":"Ressing","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.meegid.2023.105443_bb0610","first-page":"355","article-title":"Immune evasion by Epstein-Barr virus","volume":"391","author":"Ressing","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0615","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jtbi.2013.04.035","article-title":"Selection pressures give composite correlated random walks Levy walk characteristics","volume":"332","author":"Reynolds","year":"2013","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.meegid.2023.105443_bb0620","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1172\/JCI125364","article-title":"Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas","volume":"129","author":"Ruhl","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.meegid.2023.105443_bb0625","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1007\/s00018-020-03538-3","article-title":"Vaccination against the Epstein-Barr virus","volume":"77","author":"Ruhl","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.meegid.2023.105443_bb0630","doi-asserted-by":"crossref","first-page":"13105","DOI":"10.1128\/JVI.05598-11","article-title":"A virus-like particle-based Epstein-Barr virus vaccine","volume":"85","author":"Ruiss","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0635","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2328","article-title":"EBV associated T- and NK-cell lymphoproliferative diseases: a comprehensive overview of clinical manifestations and novel therapeutic insights","volume":"32","author":"Shafiee","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0640","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/blood.V98.13.3739","article-title":"Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load","volume":"98","author":"Silins","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.meegid.2023.105443_bb0645","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-3-319-13150-4_13","article-title":"Post-transplant lymphoproliferative disorders","volume":"165","author":"Singavi","year":"2015","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.meegid.2023.105443_bb0650","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/blood-2003-06-1791","article-title":"Integration of apoptosis and telomere erosion in virus-specific CD8+ T cells from blood and tonsils during primary infection","volume":"103","author":"Soares","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.meegid.2023.105443_bb0655","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/bmt.2014.2","volume":"49","author":"Solomon","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.meegid.2023.105443_bb0660","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.chom.2010.06.014","article-title":"Viral latency and its regulation: lessons from the gamma-herpesviruses","volume":"8","author":"Speck","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.meegid.2023.105443_bb0665","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1128\/JVI.74.15.6748-6759.2000","article-title":"Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1","volume":"74","author":"Steigerwald-Mullen","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0670","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1084\/jem.184.5.1801","article-title":"Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory","volume":"184","author":"Steven","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.meegid.2023.105443_bb0675","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1084\/jem.185.9.1605","article-title":"Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response","volume":"185","author":"Steven","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.meegid.2023.105443_bb0680","first-page":"905","article-title":"Experts consensus on diagnosis and treatment of Epstein-Barr virus infection-related diseases in children","volume":"59","author":"Subspecialty Group of Infectious Diseases and National Children's Epstein-Barr Virus Infection Cooperative G","year":"2021","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.meegid.2023.105443_bb0685","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fimmu.2017.00194","article-title":"CD4 CTL, a cytotoxic subset of CD4(+) T cells, their differentiation and function","volume":"8","author":"Takeuchi","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0690","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/infdis\/172.3.739","article-title":"Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses to Epstein-Barr virus in children","volume":"172","author":"Tamaki","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2023.105443_bb0695","first-page":"14","article-title":"Concomitant cytotoxic effector differentiation of CD4(+) and CD8(+) T cells in response to EBV-infected B cells","author":"Tamura","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2\u20133","key":"10.1016\/j.meegid.2023.105443_bib822","first-page":"73","article-title":"Recognition of B-CLL cells experimentally infected with EBV by autologous T lymphocytes.Immunology","volume":"60","author":"Tomita","year":"1998","journal-title":"letters"},{"key":"10.1016\/j.meegid.2023.105443_bb0700","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semcancer.2012.02.004","article-title":"The biology of EBV infection in human epithelial cells","volume":"22","author":"Tsao","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.meegid.2023.105443_bb0705","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1040-8428(02)00114-2","article-title":"Diagnosis of Epstein-Barr virus-associated diseases","volume":"44","author":"Tsuchiya","year":"2002","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.meegid.2023.105443_bb0710","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jmv.1029","article-title":"Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection","volume":"64","author":"Tsuge","year":"2001","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0715","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/rmv.441","article-title":"Latent and lytic Epstein-Barr virus replication strategies","volume":"15","author":"Tsurumi","year":"2005","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0720","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm830","article-title":"Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells","volume":"9","author":"Tugizov","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.meegid.2023.105443_bb0725","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-9-1","article-title":"Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation","volume":"9","author":"Valentine","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.meegid.2023.105443_bb0730","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1099\/jgv.0.000021","article-title":"Silencing the shutoff protein of Epstein-Barr virus in productively infected B cells points to (innate) targets for immune evasion","volume":"96","author":"van Gent","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0735","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007464","article-title":"Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in mice","volume":"14","author":"van Zyl","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.meegid.2023.105443_bb0740","doi-asserted-by":"crossref","first-page":"E46","DOI":"10.1002\/pbc.24480","article-title":"Cytokine profiles in children with primary Epstein-Barr virus infection","volume":"60","author":"Wada","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.meegid.2023.105443_bb0745","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1128\/JVI.72.1.158-163.1998","article-title":"Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect","volume":"72","author":"Wang","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0750","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1128\/JVI.72.7.5552-5558.1998","article-title":"Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells","volume":"72","author":"Wang","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0755","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jcyt.2013.07.008","article-title":"Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy","volume":"16","author":"Wang","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1016\/j.meegid.2023.105443_bb0760","first-page":"2430","article-title":"Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan","volume":"7","author":"Wang","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.meegid.2023.105443_bb0765","article-title":"HLA-DR expression level in CD8(+) T cells correlates with the severity of children with acute infectious mononucleosis","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0770","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/jmv.21445","article-title":"Regulatory T cell activity in primary and persistent Epstein-Barr virus infection","volume":"81","author":"Wingate","year":"2009","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.meegid.2023.105443_bb0775","first-page":"372","article-title":"Common questions about infectious mononucleosis","volume":"91","author":"Womack","year":"2015","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.meegid.2023.105443_bb0780","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/1547691X.2012.758199","article-title":"Clinical significance of variations in levels of Epstein-Barr virus (EBV) antigen and adaptive immune response during chronic active EBV infection in children","volume":"10","author":"Xing","year":"2013","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.meegid.2023.105443_bb0785","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s12185-019-02612-2","article-title":"Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol","volume":"109","author":"Yanagaisawa","year":"2019","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.meegid.2023.105443_bb0790","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/716926","article-title":"Evaluation of Epstein-Barr virus latent membrane protein 2 specific T-cell receptors driven by T-cell specific promoters using lentiviral vector","volume":"2011","author":"Yang","year":"2011","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.meegid.2023.105443_bb0795","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/pr.2017.178","article-title":"EBV-HLH children with reductions in CD4+ T cells and excessive activation of CD8+ T cells","volume":"82","author":"Yang","year":"2017","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.meegid.2023.105443_bb0800","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s13023-021-01976-1","article-title":"Epidemiological investigation of hemophagocytic lymphohistiocytosis in China","volume":"16","author":"Yao","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.meegid.2023.105443_bb0805","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1126\/science.1088902","article-title":"Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1","volume":"301","author":"Yin","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.meegid.2023.105443_bb0810","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1182\/blood-2014-07-591412","article-title":"Antigen-armed antibodies targeting B lymphoma cells effectively activate antigen-specific CD4+ T cells","volume":"125","author":"Yu","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.meegid.2023.105443_bb0815","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11427-016-0286-7","article-title":"Chaetocin reactivates the lytic replication of Epstein-Barr virus from latency via reactive oxygen species","volume":"60","author":"Zhang","year":"2017","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.meegid.2023.105443_bb0820","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41541-022-00587-6","article-title":"Urgency and necessity of Epstein-Barr virus prophylactic vaccines","volume":"7","author":"Zhong","year":"2022","journal-title":"NPJ Vaccines"}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134823000412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134823000412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T14:58:40Z","timestamp":1761577120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134823000412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":166,"alternative-id":["S1567134823000412"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2023.105443","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T cell-mediated immunity during Epstein\u2013Barr virus infections in children","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2023.105443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105443"}}